(Q54176403)

25 May 2018

title

Chlorambucil therapy in sympathetic ophthalmia. (English)

1 reference

25 May 2018

1 reference

C S Yang

1

1 reference

25 May 2018

J H Liu

series ordinal

2

1 reference

25 May 2018

language of work or name

English

0 references

publication date

1 April 1995

1 reference

25 May 2018

American Journal of Ophthalmology

published in

1 reference

25 May 2018

volume

119

1 reference

25 May 2018

issue

4

1 reference

25 May 2018

page(s)

482-488

1 reference

25 May 2018

Immunosuppressive Therapy of Ocular Inflammatory Diseases

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971235-8

Human sympathetic ophthalmia. An analysis of the inflammatory infiltrate by hybridoma-monoclonal antibodies, immunochemistry, and correlative electron microscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971235-8

Sympathetic ophthalmia. A long-term follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971235-8

Treatment of uveitis with methotrexate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971235-8

Cyclophosphamide Therapy of Peripheral Uveitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971235-8

The Treatment of Uveitis with Six-Mercaptopurine*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971235-8

Azathioprine in active chronic iridocyclitis. A double-blind controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971235-8

Chlorambucil for childhood nephrosis: a word of caution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971235-8

Treatment of patients with systemic lupus erythematosus including nephritis with chlorambucil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971235-8

The oncogenicity of chlorambucil in rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971235-8

Treatment of Behçet's disease with chlorambucil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971235-8

Treatment of Behcet disease with chlorambucil. A follow-up report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971235-8

Immunosuppressive Therapy for Severe Chronic Uveitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971235-8

High-dose short-term chlorambucil for intractable sympathetic ophthalmia and Behçet's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971235-8

Increased incidence of acute leukemia in polycythemia vera associated with chlorambucil therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971235-8

Gonadal effects of chlorambucil given to prepubertal and pubertal boys for nephrotic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971235-8

POSSIBLE TERATOGENIC EFFECT OF CHLORAMBUCIL ON A HUMAN FETUS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971235-8

Renal agenesis after first trimester exposure to chlorambucil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971235-8

Chlorambucil-induced myelofibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2971235-8

10.1016/S0002-9394(14)71235-8

7 January 2021

Identifiers

DOI

1 reference

25 May 2018

PubMed ID

7709973

1 reference

25 May 2018